Intellective Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 906

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 13

Intellective Bio General Information

Description

Provider of contract development and manufacturing organization (CDMO) services designed to support the development and large-scale commercial production of macromolecular biopharmaceuticals. The company offers process development, quality control, clinical and commercial GMP production, and regulatory filing services for monoclonal antibodies, antibody-drug conjugates (ADCs), and recombinant proteins, enabling biotechnology and pharmaceutical enterprises to accelerate drug time-to-market and achieve cost-effective mass production through its extensive bioreactor capacity and specialized production lines.

Contact Information

Formerly Known As
Suzhou Zhixiang Innovation Incubation Management
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 96, Yinhe Road, Southeast Street
  • Changshu
  • Suzhou, Jiangsu 215500
  • China
+86 0512
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • Number 96, Yinhe Road, Southeast Street
  • Changshu
  • Suzhou, Jiangsu 215500
  • China
+86 0512

Intellective Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intellective Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. IPO 01-Jun-2026 Announced Generating Revenue
9. Secondary Transaction - Private 18-Mar-2026 Completed Generating Revenue
8. Later Stage VC (Series C1) 04-Jul-2024 Completed Generating Revenue
7. Secondary Transaction - Private 01-Mar-2024 Completed Generating Revenue
6. Later Stage VC (Series C) 18-Aug-2022 Completed Generating Revenue
5. Secondary Transaction - Private 31-May-2022 Completed Generating Revenue
4. Early Stage VC (Series B1) 12-Jul-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 28-Jun-2021 Completed Generating Revenue
2. Early Stage VC (Series A1) 07-May-2021 $7.68M $24.4M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Nov-2020 $16.7M $16.7M Completed Generating Revenue
To view Intellective Bio’s complete valuation and funding history, request access »

Intellective Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intellective Bio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anhui Capital Asset Manager Minority
Chongqing Kexing Kechuang Equity Investment Fund Management Growth/Expansion Minority
Eastern Bell Venture Capital Venture Capital Minority
Quzhou State-owned Assets Security Capital Management Growth/Expansion Minority
Shenzhen Yunqi Private Equity Investment Fund Management Growth/Expansion Minority
You’re viewing 5 of 13 investors. Get the full list »

Intellective Bio Investments (2)

Intellective Bio’s most recent deal was a Later Stage VC with Aismay. The deal was made on 29-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aismay 29-Jul-2026 Later Stage VC Drug Discovery
Leads Biolabs 27-Nov-2024 Secondary Transaction - Private Drug Discovery
To view Intellective Bio’s complete investments history, request access »

Intellective Bio FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process